Interestingly, the antitumor activity was observed to be dependent on the expression of EGFRvIII on some, but not all tumor cells, and the activity could be significantly inhibited in the absence of CD4+ and CD8+ T-cells [57]. The gene discussed is CD8A; the disease is neoplasm.